Crizotinib Continuation Clinical Study
Clinical trial NCT05160922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05160922
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-27
- Primary completion
- 2028-03-21
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.